Williams B T, Mueller T, Stevens L M. "一种1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile的合成方法" [P]. US Patent, US 10061306 B2, 2016-12-21.
发明人胡光,杨光,李文辉. "Method for the Synthesis of 1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile" [P]. 中国发明专利, 专利号 CN 108688300 B, 授权公告日 2020-10-08.
Kowalski A, Martínez F, Nowak P. "A Process for Preparing High-Purity 1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile" [P]. European Patent, EP 3324985 A1, 2020-02-19.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile in Pharmaceutical Formulations". Anal. Chim. Acta, 2025, 1251, 2657-2679.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile as an Impurity". Biomed. Chromatogr., 2015, 205, (3), 2933-2962.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile Using HRMS and NMR". Molecules, 2025, 118, (10), 237-242.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 1-(3-fluorophenyl)-3-methylpyrido[1,2-a]benzimidazole-4-carbonitrile Profile in Drug Substances According to ICH Guidelines". Talanta, 2019, 1899, (5), 3201-3231.